John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WLL
1576
DELISTED
Whiting Petroleum Corporation
WLL
| $1.77M | 0.01% |
+70,907
| New | +$1.42M |
|
1577
MasterCraft Boat Holdings
MCFT
$599M
| $1.77M | 0.01% |
+71,104
| New | +$1.59M |
|
1578
Fortress Biotech
FBIO
$94.4M
| $1.76M | 0.01% |
36,937
-11,609
| -24% | -$503K |
|
|
SKX
1579
CALL
DELISTED
Skechers
SKX
| $1.75M | 0.01% |
48,800
+30,800
| +171% | +$1.05M |
|
1580
AXT Inc
AXTI
$4.42B
| $1.75M | 0.01% |
182,831
+148,536
| +433% | +$1.19M |
|
1581
PUT
Five Below
FIVE
$14.3B
| $1.75M | 0.01% |
10,000
-300
| -3% | -$44.4K |
|
1582
CALL
Vale
VALE
$65.2B
| $1.75M | 0.01% |
+104,400
| New | +$1.39M |
|
1583
PUT
Bread Financial
BFH
$4.14B
| $1.75M | 0.01% |
29,571
-2,506
| -8% | -$126K |
|
1584
Moody's
MCO
$88.9B
| $1.74M | 0.01% |
5,990
-36,680
| -86% | -$10.3M |
|
|
OTIC
1585
DELISTED
Otonomy, Inc.
OTIC
| $1.74M | 0.01% |
268,731
+121,133
| +82% | +$550K |
|
1586
Scotiabank
BNS
$113B
| $1.74M | 0.01% |
32,145
-1,220,667
| -97% | -$57.9M |
|
1587
PUT
Expedia Group
EXPE
$40.6B
| $1.73M | 0.01% |
13,100
-63,700
| -83% | -$7.18M |
|
1588
Matador Resources
MTDR
$6.87B
| $1.73M | 0.01% |
143,300
-702,343
| -83% | -$6.86M |
|
1589
Keros Therapeutics
KROS
$232M
| $1.73M | 0.01% |
+24,477
| New | +$1.54M |
|
1590
Primerica
PRI
$9.16B
| $1.73M | ﹤0.01% |
12,879
-22,670
| -64% | -$2.85M |
|
1591
Adobe
ADBE
$109B
| $1.72M | ﹤0.01% |
+3,438
| New | +$1.66M |
|
|
WMC
1592
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $1.72M | ﹤0.01% |
52,682
+43,230
| +457% | +$1.17M |
|
1593
CALL
Kohl's
KSS
$2B
| $1.71M | ﹤0.01% |
42,000
-129,400
| -75% | -$3.76M |
|
1594
PUT
Brinker International
EAT
$10.7B
| $1.71M | ﹤0.01% |
30,200
-3,800
| -11% | -$188K |
|
1595
RadNet
RDNT
$6.05B
| $1.71M | ﹤0.01% |
87,187
+75,031
| +617% | +$1.33M |
|
1596
CALL
RingCentral
RNG
$5.48B
| $1.71M | ﹤0.01% |
4,500
-4,500
| -50% | -$1.4M |
|
|
AMBR
1597
Amber International Holding Ltd
AMBR
$102M
| $1.71M | ﹤0.01% |
19,960
+1,334
| +7% | +$103K |
|
|
HZNP
1598
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.7M | ﹤0.01% |
23,292
-423,991
| -95% | -$31.5M |
|
1599
PUT
Cerence
CRNC
$363M
| $1.7M | ﹤0.01% |
16,900
+5,700
| +51% | +$425K |
|
|
MDRX
1600
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.69M | ﹤0.01% |
117,281
-38,935
| -25% | -$471K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.